AMOEBA (EPA:ALMIB) - Half-year review of the liquidity contract
Transparency directive : regulatory news
03/01/2019 17:40
Click here to download pdf version
PRESS RELEASEChassieu, 3rd January 2019
Half-year review of the liquidity contract
Pursuant to the liquidity contract established by AMOEBA with PORTZAMPARC
Trading Company, as of 31st December 2018, the liquidity account held the
following assets:
* 12,148 AMOEBA shares,
* EUR 26,408.77
It is recalled that at the time of implementation, the following amount was
held in the liquidity account:
* 200,000.00 euros.
About AMOEBA:
Amoéba's ambition is to become a major player in the treatment of bacterial
risk in the fields of water, healthcare and plant protection. Our biological
solution is an alternative to chemical products widely used today. Amoéba is
currently focusing on the market of industrial cooling towers estimated at
EUR1.7Bn (1) on a global chemical biocide market for water treatment, evaluated
at EUR21Bn (2) and on the biocontrol market for plant protection estimated
globally at EUR1.6Bn (4). In the future, the Company is looking at developing
new applications such as chronic wound care, estimated at EUR 751 million (3)
in the USA. Sales of associated products with healthcare, biocides and crop
protection are subject to the Company being granted local regulatory market
authorizations.
Created in 2010, based in Chassieu (Lyon, France) with a subsidiary in Canada
and in the United States, Amoéba is quoted on the compartment C of Euronext
Paris. The Company is a member of the BPIfrance Excellence network and is
eligible for the PEA-PME SME equity savings plan setup. More information on
www.amoeba-biocide.com.
(1) : Amoéba data combined from sources: DRIRE 2013, Eurostat, ARHIA 2013
(2) : Sources combined by Amoéba from water treaters, Freedonia, Eurostat et
MarketsandMarkets (3): BCC Research, "Markets for Advanced Wound Management
Technologies," Wellesley, MA, 2017 (4): Biopesticides Worldwide Market 2013,
CPL, Wallingford, UK
Contacts :
Amoéba
Valérie FILIATRE
Directeur administratif et Financier
04 26 69 16 00
valerie.filiatre@amoeba-biocide.com
Actifin
Ghislaine GASPARETTO
Communication financière 01 56 88 11 11
ggasparetto@actifin.fr
AMOEBA's latest news
28/03/2024 18:30
15/02/2024 08:45
05/02/2024 08:45
15/12/2023 17:45
23/11/2023 17:45
18/10/2023 17:45
16/10/2023 17:45
12/10/2023 08:55
05/10/2023 18:00
22/09/2023 18:00
Other stories
25/04/2024 15:40
25/04/2024 15:40
25/04/2024 13:17
25/04/2024 15:02
25/04/2024 03:56
25/04/2024 12:20
25/04/2024 14:40
25/04/2024 15:52
25/04/2024 11:29
25/04/2024 15:06
25/04/2024 09:11
25/04/2024 09:31
25/04/2024 14:29
25/04/2024 12:31
25/04/2024 16:28
25/04/2024 13:54
25/04/2024 09:58
25/04/2024 14:40
25/04/2024 12:01
25/04/2024 08:13
25/04/2024 12:30
24/04/2024 21:21
25/04/2024 15:48
25/04/2024 13:55
25/04/2024 09:01
25/04/2024 13:04
25/04/2024 15:00
25/04/2024 15:23
25/04/2024 10:15
25/04/2024 10:11
25/04/2024 14:18
24/04/2024 11:51
25/04/2024 12:15
25/04/2024 11:33
25/04/2024 06:00
25/04/2024 06:20
25/04/2024 14:52
24/04/2024 23:40